Similar articles

• Why neuroleptic withdrawal in schizophrenia?

  Carpenter WT Jr, Tamminga CA. Carpenter WT Jr, et al. Arch Gen Psychiatry. 1995 Mar;52(3):192-3. doi: 10.1001/archpsyc.1995.03950150024003. Arch Gen Psychiatry. 1995. PMID: 7872843 No abstract available.
• Neuroleptic withdrawal in schizophrenic patients. An idea whose time has come.

  Meltzer HY. Meltzer HY. Arch Gen Psychiatry. 1995 Mar;52(3):200-2. doi: 10.1001/archpsyc.1995.03950150032005. Arch Gen Psychiatry. 1995. PMID: 7872845 No abstract available.
• The early course of schizophrenia and long-term maintenance neuroleptic therapy.

  Nuechterlein KH, Gitlin MJ, Subotnik KL. Nuechterlein KH, et al. Arch Gen Psychiatry. 1995 Mar;52(3):203-5. doi: 10.1001/archpsyc.1995.03950150035006. Arch Gen Psychiatry. 1995. PMID: 7872846 No abstract available.
• Long-acting injectable antipsychotics in the treatment of schizophrenia: their role in relapse prevention.

  Agid O, Foussias G, Remington G. Agid O, et al. Expert Opin Pharmacother. 2010 Oct;11(14):2301-17. doi: 10.1517/14656566.2010.499125. Expert Opin Pharmacother. 2010. PMID: 20586707 Review.
• The treatment of tardive dyskinesia.

  Raja M. Raja M. Schweiz Arch Neurol Psychiatr (1985). 1996;147(1):13-8. Schweiz Arch Neurol Psychiatr (1985). 1996. PMID: 8685689 Review.